Abstract
Lenvatinib is a tyrosine kinase inhibitor (TKI) with antiproliferative and antiangiogenic effects indicated for the treatment of progressive, locally advanced or metastatic progressive thyroid carcinoma, refractory to radioactive iodine therapy. Antiangiogenic therapies induce ischemic necrosis of tumor tissue, with increased risk of hemorrhagic complications. The management of hemorrhagic risk is based on precautionary measures and for any surgical procedure, it is advised to interrupt the treatment in order to avoid complications. 'Flare-up' of tumor activity may follow TKI interruption. However, it is not known if continuing TKIs during minimally invasive interventions is safe. We report here the first case in which an embolization of metastasis is performed without interrupting lenvatinib treatment. The procedure was successful and free of complications.
References
Mar 24, 1998·Annual Review of Medicine·B R Zetter
Jan 8, 2003·Seminars in Oncology·Judah Folkman
Oct 4, 2006·The Journal of Clinical Investigation·Michael R MancusoDonald M McDonald
Dec 25, 2008·Acta Oncologica·Pascal WolterPatrick Schöffski
May 20, 2009·Acta Oncologica·Ingrid M E DesarCarla M L van Herpen
May 25, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J Ayllon, G Pignot
Nov 5, 2010·Journal of Thyroid Research·Michael A SiaJames D Brierley
Mar 1, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·G PignotM Zerbib
Jun 15, 2012·Thrombosis Research·Francesca Elice, Francesco Rodeghiero
Nov 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Austin DuffyTim F Greten
Aug 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W-X QiY Yao
Nov 5, 2013·Critical Reviews in Oncology/hematology·Wei-Xiang QiYang Yao
Apr 29, 2014·Lancet·Marcia S BroseUNKNOWN DECISION investigators
Jan 27, 2015·The Oncologist·Joshua J Gruber, A Dimitrios Colevas
Feb 12, 2015·The New England Journal of Medicine·Martin SchlumbergerSteven I Sherman
Jun 25, 2015·Cancer Treatment Reviews·Raquel M CarneiroFrancis J Giles
Jun 23, 2016·Oncotarget·Chenjing ZhuYue Xiao
Feb 23, 2017·Archives of Endocrinology and Metabolism·Angelica SchmidtMartin J Schlumberger
Mar 9, 2017·Endocrine-related Cancer·Marcia S BroseIwao Sugitani
Jun 30, 2018·BMC Cancer·Masayuki Tori, Toshirou Shimo
Jul 23, 2018·Cancer Treatment Reviews·Jaume CapdevilaEnrique Grande
Mar 19, 2019·Endocrinology, Diabetes & Metabolism Case Reports·Taisuke UchidaMasamitsu Nakazato